CME Group vs. Robinhood: Two Outlets Compare Growth and Risk
· 2 sources
The Motley Fool and Pluang compare CME Group and Robinhood Markets on revenue growth, profitability, debt and risk ahead of 2027.
What happened
The Motley Fool and Pluang each published a comparison of CME Group and Robinhood Markets (HOOD), looking at the two financial companies ahead of 2027.
The Motley Fool says Robinhood's revenue grew far faster than CME's over the latest 12 months, while its debt load points to a very different picture of financial risk.
Pluang describes CME as a leading global derivatives marketplace with a 63.1% net margin, low debt and a dividend yield of 1.7%. It says Robinhood posted 21.1% revenue growth and runs a diversified retail platform, but faces regulatory scrutiny and higher debt. Pluang's article favors CME for 2027 given market uncertainty.
Context
Robinhood operates a retail-focused trading platform, while CME Group runs a major derivatives exchange, so the two businesses differ in model and customer base.
Why it matters
The comparison shows how analysts weigh fast growth against balance-sheet strength and regulatory exposure when assessing financial stocks such as Robinhood.
Stocks in this story
Price changes are shown for the trading day of the story and are a coincidence in time, not proof that the news caused them. Figures are ATLAS data from our database.
$62.17−9.44% vs. previous close ($68.65) · November 20
Fair value (ATLAS)
$43.00Fair range: $38.70 to $47.30The price ($62.17) is 44.6% above that figure.
Chance of a rise in 1 month
46%Probability of closing higher than today within 21 sessions.Normal range: half of the scenarios end between $53.90 and $69.37; 9 in 10, between $43.10 and $86.77.
Fair value, probabilities and earnings for every stock. Free account, no card. Information, not advice.
Information, not advice. This content is informational and is not an investment recommendation or an offer to buy or sell securities. ATLAS estimates come from statistical models using public data, can be wrong, and past performance does not guarantee future results. Disclaimer
ATLAS Signals
ATLAS Signals, every week
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy